Tobacco Use Clinical Trial
Official title:
Modeling Tobacco Regulatory Impacts in Appalachia Using the Experimental Tobacco Marketplace
Verified date | April 2024 |
Source | University of Kentucky |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this project is to look at the effect of proposed tobacco product regulations in Appalachian Kentucky. Appalachian Kentucky is a diverse and underserved rural area that would benefit from more tobacco regulation research. Researchers will study the effects of three proposed tobacco product regulations among users of tobacco products in Appalachian KY. Researchers will also study how degree of rurality effects how those regulations impact behavior. Participants will be asked to complete online surveys and tests, online shopping sessions in a simulated Experimental Tobacco Marketplace, and track their tobacco product use throughout the 9-week experiment.
Status | Not yet recruiting |
Enrollment | 473 |
Est. completion date | August 2028 |
Est. primary completion date | February 2028 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years and older |
Eligibility | Inclusion Criteria: - At least 21 years old - Consume nicotine and/or tobacco products daily - Have no plans to quit nicotine/tobacco consumption or seek treatment in the subsequent 9 weeks - Read and understand English Exclusion Criteria: |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Mikhail N Koffarnus | National Institute on Drug Abuse (NIDA) |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Aggregate behavioral economic demand across all participants under the proposed regulatory environments | Participants will complete trials of the Experimental Tobacco Marketplace wherein the price of a target commodity will be increased. Nonlinear mixed effects modeling will be used to fit a curve to estimate the number of products purchased at each price and the analysis will result in an measure of overall price sensitivity under each of the regulatory conditions. | Assessed at study week 0 and at study week 9 | |
Primary | Aggregate behavioral economic substitution across all participants under the proposed regulatory environments | Participants will complete trials of the Experimental Tobacco Marketplace wherein the price of alternative products will be fixed across trials and their usual product will change price. Mixed effects modeling will be used to fit a curve to estimate the slopes and intercepts of these alternative products, revealing the degree to which participants will choose to purchase each alternative product as the price of the participant's usual product increases. | Assessed at study week 0 and at study week 9 | |
Secondary | Timeline Follow-Back (TLFB): Average of marijuana and nicotine use quantity | Self-reported marijuana and nicotine product use separated by product type and flavor for the past 60 days. | Assessed at study week 0 and at study week 9 | |
Secondary | Fagerström Test for Nicotine Dependence (FTND) | Measure of dependence symptoms, measured on a scale of 0 to 10. A higher score indicates a higher physical dependence on nicotine. | Assessed at study week 0 and at study week 9 | |
Secondary | Minnesota Nicotine Withdrawal Scale (MNWS) | Assesses Withdrawal Symptoms. Scored on an ordinal scale ranging from 0 to 3. A higher score indicates increased intensity of symptoms. | Assessed at study week 0 and at study week 9 | |
Secondary | Hypothetical quantity purchased in purchase tasks | Measures valuation by assessing hypothetical consumption across a price range and across the range of products used by participants in the past 60 days. | Assessed at study week 0 and at study week 9 | |
Secondary | Delay Discounting Tasks | Assesses valuation for future money and nicotine products. | Assessed at study week 0 and at study week 9 | |
Secondary | Activity Level Questionnaire - Substance Use Version (ALQ-SUV) | Measures past-month reinforcement from substance-related and substance-free activities, yielding a reinforcement ratio quantifying the proportion of overall reinforcement obtained from nicotine use. The ratio ranges from 0 to 1, with a higher score indicating a greater proportion of reinforcement received from drug-related activities relative to total reinforcement. | Assessed at study week 0 and at study week 9 | |
Secondary | Breath Carbon Monoxide (CO) | Breath carbon monoxide readings collected using our app | Collected twice daily through the 10 week duration of the study | |
Secondary | Salivary Cotinine | Salivary cotinine collected with rapid test, verified via smartphone app | Collected with assessment sessions at study weeks 0 and 9, as well as twice weekly remotely during interim sampling period | |
Secondary | Self-reported nicotine product use | The number of tobacco cigarettes, marijuana cigarettes, and other nicotine/tobacco products consumed. Will be collected with our app. | Collected daily from study week 1 to study week 9 | |
Secondary | Self-reported withdrawal symptom severity | On a scale from 0 to 9, participants will report their withdrawal symptom severity in our smartphone app. A higher score indicates more severe symptoms. | Collected daily from study week 1 to study week 9 | |
Secondary | Self-reported nicotine craving intensity | On a scale from 0 to 9, participants will report their nicotine craving intensity in our smartphone app. A higher score indicates more intense cravings. | Collected daily from study week 1 to study week 9 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Recruiting |
NCT06033599 -
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
|
Phase 3 | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT06105424 -
BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability
|
N/A | |
Completed |
NCT01311830 -
Enhancing Smoker Utilization of the Minnesota Quitline Through Support Persons
|
N/A | |
Completed |
NCT04566198 -
Smoking in the Paris Fire Brigade and Comparison According to the Type of Service (Permanent or On-call)
|
||
Completed |
NCT04107779 -
Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to JUUL ENDS
|
N/A | |
Completed |
NCT05092919 -
The Effect of Sweet Flavoring on the Rewarding and Reinforcing Value of Cigarillo Use Among Young Adults
|
Early Phase 1 | |
Terminated |
NCT05274217 -
Journey of Transformation Curriculum for Native American Adolescents
|
N/A | |
Enrolling by invitation |
NCT06042361 -
Enhancing Equity in Smoke-free Housing
|
N/A | |
Withdrawn |
NCT03352635 -
Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking Clinical and Biomarkers Core
|
N/A | |
Completed |
NCT03235713 -
EMA for Tobacco Control Policy Research
|
||
Completed |
NCT03151421 -
Air Quality Feedback to Reduce Second-hand Smoke (SHS) Exposure in the Home
|
N/A | |
Completed |
NCT03446170 -
Effect of Cigarette Pack Warnings and Packaging Among Young Adult Smokers
|
N/A | |
Completed |
NCT04104152 -
CSD190203: A Study to Determine Subject Puffing Patterns of an Electronic Nicotine Delivery System in an Ambulatory Setting
|
N/A | |
Not yet recruiting |
NCT05999383 -
Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
|
Phase 2 | |
Recruiting |
NCT04429568 -
THC Crossover Study
|
N/A | |
Completed |
NCT04632030 -
Shrinking the Size of the Tobacco Power Wall
|
N/A | |
Completed |
NCT04143256 -
Evaluating Selected Constituents in the Exhaled Breath Samples
|
N/A |